DBV Technologies S.A. - American Depositary Shares (DBVT) Covered Calls

DBV Technologies SA is an epicutaneous immunotherapy company. The Company is engaged in research and development of patient-friendly therapy for food and pediatric allergy patients.

You can sell covered calls on DBV Technologies S.A. - American Depositary Shares to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for DBVT (prices last updated Thu 4:16 PM ET):

DBV Technologies S.A. - American Depositary Shares (DBVT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
0.69 0.00 0.65 0.71 41K - 0.0
Covered Calls For DBV Technologies S.A. - American Depositary Shares (DBVT)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
May 17 2.5 0.00 0.71 0.0% 0.0%
Jun 21 2.5 0.00 0.71 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

DBV Technologies SA is a clinical-stage biopharmaceutical specialty company, which focuses on developing a novel technology platform called Viaskin. Viaskin is an electrostatic patch, which offers a convenient, self-administered, non-invasive immunotherapy to patients. It has designed two products candidates: Viaskin Peanut and Viaskin Milk. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Bagneux, France.